Back to Search
Start Over
PeptiDream inks collaboration and licensing pact with Genentech to discover & develop novel peptide-radioisotope drug conjugates
- Source :
- PharmaBiz. September 21, 2023
- Publication Year :
- 2023
-
Abstract
- PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company, announced a new multi-target collaboration and license agreement with US-based Genentech, a member of the Roche Group, focused on the discovery and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.766002807